Gaucher and Parkinson diseases
Unexpectedly related
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Over the last 4 years, increasing evidence has pointed to an unexpectedly close relationship between Gaucher disease (OMIM 606463) and Parkinson disease (PD) (OMIM 168600). Gaucher disease is a lysosomal storage disorder caused by mutations in the glucocerebrosidase gene leading to intracellular buildup of glucosylceramide. Although Gaucher disease is one of the classic, recessive disorders, the genotype–phenotype relationships for the disease are not clear and there is an enormous amount of unexplained phenotypic heterogeneity with some individuals having prominent spleen or liver symptoms and others having a neurodegenerative disease phenotype.1 Although there have been brain neuropathologic examinations of persons dying of Gaucher disease, these have generally been of young patients and the occurrence of α-synuclein positive Lewy bodies (hallmark of PD) has only been assessed in a few elderly cases.2
One of the first hints that there might be a relationship between the two conditions came with the observation of PD in the relatives of individuals with Gaucher syndrome.3 …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Alert Me
Recommended articles
-
Articles
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson diseaseL. N. Clark, B. M. Ross, Y. Wang et al.Neurology, September 17, 2007 -
Brief Communications
Mutations in the glucocerebrosidase gene and Parkinson disease: Phenotype–genotype correlationJudith Aharon-Peretz, Samih Badarny, Hanna Rosenbaum et al.Neurology, September 07, 2005 -
Brief Communications
Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian populationM. Toft, L. Pielsticker, O. A. Ross et al.Neurology, February 13, 2006 -
Article
Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 ConsortiumKaren Marder, Yuanjia Wang, Roy N. Alcalay et al.Neurology, June 10, 2015